Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-related Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01941082
What this trial is testing

RO6867461 Administered in Single- and Multiple-Ascending Doses in Patients With Wet Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
Hoffmann-La Roche 24
Not applicableStudy completedNCT03228446
What this trial is testing

The Effects of Attentional Filter Training on Working Memory

Who this might be right for
Cognitive DeclineHealthyAge-related Cognitive Decline
German Center for Neurodegenerative Diseases (DZNE) 60
Large-scale testing (Phase 3)Study completedNCT07214740
What this trial is testing

Study to Evaluate a Pegcetacoplan (Syfovre®) Prefilled Syringe

Who this might be right for
Geographic Atrophy Secondary to Age-related Macular Degeneration
Apellis Pharmaceuticals, Inc. 44
Not applicableStudy completedNCT06184360
What this trial is testing

Real-world Evaluation of BEOVU (Brolucizumab) Effectiveness and Durability for Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD)

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration
Novartis Pharmaceuticals 2,079
Not applicableStudy completedNCT00005297
What this trial is testing

Age-related Prevalence of Sleep Respiratory Disturbances

Who this might be right for
Lung DiseasesHeart DiseasesHypertension+1 more
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableStudy completedNCT00668213
What this trial is testing

Antioxidant Systems and Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
Vanderbilt University 143
Not applicableWithdrawnNCT02457026
What this trial is testing

Adjunctive Photodynamic Therapy + Aflibercept vs. Afilbercept Alone for PDA in NV AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Duke University
Large-scale testing (Phase 3)Ended earlyNCT02247479
What this trial is testing

A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Who this might be right for
Geographic Atrophy
Hoffmann-La Roche 906
Not applicableUnknownNCT03944070
What this trial is testing

Management of Patients With Neovascular Age-related Macular Degeneration Undergoing Cataract Surgery

Who this might be right for
Wet Macular DegenerationCataract Extraction
Ophthalmica Eye Institute 16
Not applicableUnknownNCT05635266
What this trial is testing

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

Who this might be right for
Age-Related Macular DegenerationAllergiesAlpha-Gal Syndrome+44 more
Sanguine Biosciences 20,000
Not applicableStudy completedNCT01040546
What this trial is testing

The Effect of a Diet- and Exercise- Related Weight Control Intervention Program on Obesity in Adult Aged 40 and Over

Who this might be right for
Metabolic SyndromeObesity
China Medical University Hospital 240
Not applicableStudy completedNCT05988827
What this trial is testing

Effect of Minimizing Light Exposure Intensity on Macular Function After Cataract Surgery in Patients With Early or Intermediate AMD

Who this might be right for
Macular Degeneration, Age RelatedCataract
Elsan 42
Testing effectiveness (Phase 2)Ended earlyNCT04566445
What this trial is testing

HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005

Who this might be right for
Dry Age-related Macular Degeneration
Gyroscope Therapeutics Limited 255
Not applicableStudy completedNCT06495203
What this trial is testing

Understand the Usage of an Artificial Intelligence Technology Called DARWEN for Eye Disorders and to Find Out the Factors Influencing Treatment Frequencies in People With nAMD and RVO

Who this might be right for
Neovascular Age-related Macular DegenerationRetinal Vein Occlusion
Bayer 1,350
Not applicableLooking for participantsNCT06619405
What this trial is testing

AMD and Validation Rod-Meditated Dark Adaptation With Everyday Task Performance

Who this might be right for
Age-Related Macular Degeneration
Duke University 100
Not applicableStudy completedNCT03537729
What this trial is testing

Effects of Visual Cues and Education for People Who Live Within Long Term Care Communities to Assist in Wayfinding

Who this might be right for
Alzheimer DiseaseAlzheimer DementiaAge-Related Memory Disorders+1 more
Grand Valley State University 172
Large-scale testing (Phase 3)Active Not RecruitingNCT05112861
What this trial is testing

A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus Pre-filled Syringe in Subjects With Visual Impairment Due to Retinal Disorders

Who this might be right for
Age-Related Macular DegenerationNeovascular Age-related Macular DegenerationWet Macular Degeneration+2 more
Outlook Therapeutics, Inc. 120
Post-approval studies (Phase 4)Study completedNCT02944227
What this trial is testing

Efficacy of Fixed Monthly Dosing of Ranibizumab in Neovascular Age-related Macular Degeneration

Who this might be right for
Wet Macular Degeneration
Seoul National University Hospital 20
Not applicableStudy completedNCT01712841
What this trial is testing

Non-exudative Age-related Macular Degeneration

Who this might be right for
Non-exudative Age-related Macular Degeneration
Oregon Health and Science University 30
Not applicableStudy completedNCT00465400
What this trial is testing

Oxidative Stress in Patients With Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
University Hospital, Basel, Switzerland 12
Next Page